Sana Biotechnology's market cap is currently $674.27M. The company's EPS TTM is $-1.41; its P/E ratio is ―; Sana Biotechnology is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -30.86M	$ -27.73M	$ -17.91M	$ -10.17M	$ -3.92M
Operating Income	$ -326.90M	$ -272.56M	$ -356.91M	$ -286.15M	$ -141.15M
EBITDA	$ -252.39M	$ -256.94M	$ -356.91M	$ -287.03M	$ -138.90M
Net Income	$ -283.25M	$ -266.39M	$ -344.18M	$ -278.64M	$ -130.78M
Balance Sheet
Cash & Short-Term Investments	$ 205.19M	$ 434.01M	$ 746.88M	$ 412.00M	$ 138.98M
Total Assets	$ 565.30M	$ 822.72M	$ 1.13B	$ 730.30M	$ 415.70M
Total Debt	$ 104.10M	$ 108.25M	$ 110.94M	$ 71.91M	$ 48.21M
Net Debt	$ -29.42M	$ -68.51M	$ -142.09M	$ -340.09M	$ -31.82M
Total Liabilities	$ 277.79M	$ 323.40M	$ 400.90M	$ 1.15B	$ 558.24M
Stockholders' Equity	$ 287.51M	$ 499.31M	$ 728.50M	$ -421.18M	$ -142.54M
Cash Flow
Free Cash Flow	$ -273.61M	$ -310.93M	$ -280.92M	$ -161.85M	$ -111.69M
Operating Cash Flow	$ -253.58M	$ -290.05M	$ -251.05M	$ -137.98M	$ -85.50M
Investing Cash Flow	$ 172.01M	$ 210.56M	$ -245.80M	$ -252.56M	$ -87.86M
Financing Cash Flow	$ 31.65M	$ 4.91M	$ 631.75M	$ 435.69M	$ 223.73M

Currency in USD

Sana Biotechnology Earnings and Revenue History

Income Statement >

Sana Biotechnology Debt to Assets

Balance Sheet >

Sana Biotechnology Cash Flow

Cash Flow >

Sana Biotechnology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing